LM
MXCT icon

Luminus Management’s MaxCyte MXCT Stock Holding History

Luminus Management’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74.5K Sell
60,604
-1,089,396
-95% -$1.09M 0.05% 30
2026
Q1 		$808K Buy
1,150,000
+913,505
+386% +$853K 0.49% 16
2025
Q4 		$367K Buy
236,495
+11,495
+5% +$18.4K 0.32% 18
2025
Q3 		$356K Buy
+225,000
New +$391K 0.32% 16

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Luminus Management's MXCT Position: Q2 2026 in Review

Luminus Management reduced its MaxCyte (MXCT) stake by 95% in Q2 2026, selling an estimated $1.09M and leaving 60,604 shares worth $74.5K. The position accounts for 0.05% of the portfolio, ranked #30.

Luminus Management first reported a position in MXCT in Q3 2025 and has held it in 4 quarters since. The position peaked at $808K in Q1 2026. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Luminus Management held 60,604 shares of MaxCyte worth $74.5K as of Q2 2026.
  • Luminus Management sold 1,089,396 MaxCyte shares in Q2 2026, an estimated $1.09M.
  • MaxCyte made up 0.05% of Luminus Management's portfolio in Q2 2026, its #30 holding.
  • Luminus Management first reported a position in MaxCyte in Q3 2025 and has held it in 4 quarters since.
  • Luminus Management's MaxCyte position peaked at $808K in Q1 2026.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Luminus Management's 13F filing for Q2 2026, filed 14 Aug 2026.